We extend a warm welcome to 2025. As we step into this new year, we are thrilled to kick off with our first Topic Series of 2025 where we present a Q&A with our CEO Craig Fallshaw and discuss new product development for 2025.
Join us as we embark on this journey together, exploring new ideas and fostering collaboration in the year to come. Let's make 2025 a remarkable year filled with innovation, progress, and shared achievements!
Q&A with Craig Fallshaw CEO
Where do you draw your inspiration from for CMG?
When I was working for my Dad, I noticed that there was a bunch of start up brands that just got zero service from big manufacturers, so I decided that would be a good niche for CMG. We try hard to be make our customer service the difference between us and our competitors, we are not perfect but have built the business from $0 to current based on a customer service ethos. Start up and SME is a far more exciting space to play in than the big end of town. I love helping people turn their ideas into products.
What is your vision for CMG? To be a place that SME and start up brands can use as a one stop shop – everything you need to bring a listed medicine to market, we do.
|
|
What is different about CMG? People with 20- 30 years of industry experience at your disposal and we actually care about the success of our customers, I still have customers that have been with me since we started in my mates warehouse at Brookvale in 2010 – we do the whole process- from formulation to delivery, regs and stability – all in one place
|
|
Do you have any favourite ingredients? Vitamin K2 of course, some say it is Weston A price's factor X, and it is the only nutrient that carboxylates Osteocalcin and Matrix GLA protein – herb wise , sleep is a big issue for me so ziziphus and cal poppy would be my favourites , although I am liking the new stand alone L theanine as well.
|
|
Do you have any favourite hobbies? Used to be photography, but now its surf club and ocean swimming – I love being in the ocean and competed in the Big Billy swim on jan 12th, which was great fun. |
|
Founder Craig Fallshaw's knowledge of complementary medicine – its manufacture, formulation, active ingredients, and business processes – is in his blood, after all, he began his career over 30 years ago in the family business, a contract manufacturer that had been founded by his grandfather in 1972.
Craig built upon this manufacturing knowledge and experience with experience in sales and marketing, giving him a unique insight into the complementary medicine industry. In 2010, he founded Complementary Medicines Group (CMG), to provide full service to the complementary medicines, food products, and over-the-counter pharmaceuticals industries.
New Product Development (NPD) for 2025
Dr Brad McEwen PhD, MHSc, MPH, BHSc
2024 marked a significant period for the industry, characterised by substantial new product development (NPD) and overall industry growth. At present, the Australian complementary medicines industry is valued at an impressive $6.2 billion annually. There has been a surge in consumer interest and engagement in complementary medicines. Approximately 75% of households across the nation utilise complementary medicines into their health and wellness routines, with mental health emerging as the primary health concern. Engaging in NPD is crucial for strengthening your brand and achieving a more pronounced presence in the market.
Overall, 2024 has set the stage for a transformative era in the complementary medicines industry, characterised by a robust market presence, a focus on mental health, and a commitment to delivering safe and effective products that resonate with the needs of consumers.
Dr Brad serves as the Head of Products and Innovation here at CMG. His role involves overseeing the development of cutting-edge health products and ensuring compliance with regulatory standards. In 2024, he received the Complementary Medicines Industry Contributor of the Year award. Dr Brad's tips for NPD in 2025:
- Utilising traditional wisdom and science enhances the quality of a product.
- A targeted approach is generally more successful than "throwing everything" into a formula and lowers the risk of cannibalising a product range.
- Selecting an appropriate mechanism or mechanisms of action play a major role in the effects of a product, as it directly influences how well the product performs its intended function.
- Selecting the appropriate mechanisms ensures that the product can effectively target the desired issue or need, leading to optimal results for the consumer.
- Selecting the ingredients to meet or align with the selected mechanism/s of action play a major role in the success of a product. Each ingredient plays a specific role in the overall formulation, and its compatibility with the chosen mechanisms can significantly enhance or hinder the product's performance.
- If the ingredients do not support the mechanisms of action, the product may fall short of its claims, leading to customer dissatisfaction and potential harm to the brand's reputation.
- Synergy between the chosen mechanisms and the selected ingredients can also impact other factors such as safety, stability, and user experience. A well-formulated product that harmonises these elements is more likely to succeed in a competitive market, as it not only meets consumer expectations but also builds trust and loyalty.
CMG is the manufacturer of choice for your products and NPD.
For More Information on Manufacturing of your products
For more information on manufacturing your products, contact Craig This email address is being protected from spambots. You need JavaScript enabled to view it. or Kirsten This email address is being protected from spambots. You need JavaScript enabled to view it. . Additionally, you can call us on 02 9091 0264 to organise a visit to our state-of-the-art factory in Warriewood, NSW. We welcome you to visit and tour our factory and see everything in action.
Comments